Shadi Tabibian: A New Era in von Willebrand Disease Treatment
Shadi Tabibian, Deputy of research at Blood Diseases Research Centers in Iran University of Medical Sciences, shared a post on LinkedIn:
“A New Era in von Willebrand Disease Treatment
For decades, the management of von Willebrand disease has relied mainly on von Willebrand factor concentrates,desmopressin,antifibrinolytic agents, and hormonal therapies.
Although these treatments remain effective for many patients, important unmet needs persist, including treatment burden, variable clinical response, limited prophylactic options, and reduced quality of life.
A new generation of therapeutic strategies is now emerging.
These approaches include:
- Antibodies designed to increase endogenous VWF and factor VIII levels
- Novel agents for type 2B VWD-associated thrombocytopenia
- FVIII-mimetic and rebalancing therapies
- Engineered factor VIII molecules with prolonged half-life
- Platelet-inspired synthetic nanoparticles
- Long-acting antifibrinolytic strategies using siRNA
- Gene therapy, allele-selective silencing, and CRISPR-based gene editing
The most important shift is the movement away from a one-size-fits-all model toward phenotype-directed and personalized treatment.
Not every therapy will be appropriate for every subtype of VWD. Future success will depend on matching the mechanism of treatment to the patient’s VWD type, bleeding phenotype, clinical needs, and individual risk profile.
These innovations may ultimately reduce treatment burden, expand prophylactic options, and improve the quality of life of people living with VWD.”
Other posts featuring Shadi Tabibian on Hemostasis Today.
-
Sep 27, 2026, 15:49Rana Al-Hrout: Iron Deficency – Is Ferritin 15ng/mL or Less Still the Cutoff?
-
Sep 27, 2026, 15:49Ayushi Sharma: What I Thought Transfusion Medicine Would Be vs What It Actually Is
-
Sep 27, 2026, 15:48William Wallace: How Much Human Research Is Behind the Supplements We Take?
-
Sep 27, 2026, 15:46Franck Perraudin: Lp(a) Lowering Alone May Not Be Enough
-
Sep 27, 2026, 15:41Ahmed Hamandi: Sharing Real-World HSCT Experience at the Iraqi Society of Haematology Conference
-
Sep 27, 2026, 15:39Co-creating Digital Support With Young Stroke Survivors – European Stroke Organisation
-
Sep 27, 2026, 15:39Eleri Schiavone: Celebrating 80 Years of the Welsh Blood Service
-
Sep 27, 2026, 15:38Jessica Garcia: Standing Where VWD Was First Recognized 100 Years Later
-
Sep 27, 2026, 15:37Heghine Khachatryan: A Meaningful Step Forward for Inherited Blood Disorders in Africa